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Hemodynamic measurement is now an important and
feasible adjunct to clinical practice. Its successful ap-
plication to alleviate illness in human beings is evident
in its contribution to an understanding of the patho-
physiology of disease and the efficacy of various inter-
ventions to alter the course of a variety of diseases. Its
application is widespread in the high risk patient
Observation and common clinical skills alone have not proved
adequate to determine many important aspects of cardio-
vascular function, or to monitor circulatory changes in a
time frame that permits intervention. For this reason. the
past decade has been characterized by a virtual explosion
in a variety of invasive and noninvasive techniques to pro-
vide information on the mechanical function of the heart
and the factors that affect it. It is reasonable in this age of
computers and communications and microwaves and mi-
crosensors to anticipate still further advances in the tech-
niques and application of measurement and monitoring.
This review examines the "invasive" measurement of
cardiac output and intravascular pressures and resistances
as an accepted part of modem cardiology and its role in the
care of the critically ill patient. Acceptance of the clinical
value of invasive hemodynamic measurements and moni-
toring is not based on structured clinical trials, although
these have been advocated in the past (l). Indeed, it is
obvious to all that morbidity and mortality are many times
greater in monitored than in nonmonitored patients. How-
ever, the logic that decisions concerning prognosis and ther-
apy are made more readily, more rapidly and with greater
confidence when based on quantitative measurements of
significant variables of cardiovascular function appears to
be persuasive in the minds of many physicians and health
care personnel. For example, this facility in decision mak-
ing allows for the acceptance of high risk patients for needed
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undergoingsurgery and the criticallyill medically treated
patient. Hemodynamic measurement permits accurate
determination of the state and, if necessary, of the con-
tinuously changing function of the heart as related to
disease process and guides treatment and interventions
on a rational physiologic basis.
surgical procedures who would have been rejected 10 or
more years ago on the basis of unsuitability for operation.
A colleague* has written. "Over the years I have been
a part of progress in intraoperative cardiovascular monitor-
ing. In the 70's we had sometimes heated discussions over
whether or not an indwelling arterial catheter should be
inserted! Then. we "progressed" to question the value of
flow-directed pulmonary artery catheters. But, after we be-
gan to use the more advanced technology, we discovered
so much benefit that we continue to still further expand the
use of invasive monitoring first to the obviously critical
patient and then to less critical but at risk individuals ...
the subsequent explosion of knowledge of how to effectively
intervene to preserve and improve impaired heart function
in coronary disease patients undergoing cardiac surgery has
been truly spectacular and personally rewarding." Under
these circumstances of developing knowledge and changing
techniques and clinical indications, elaborate randomized
trials to "prove" effectiveness are impractical and would
probably fail to provide the desired guidelines even if brought
to completion.
In broad review. the question "Has hemodynamic mon-
itoring been of significant value in the management of car-
diovascular derangements?" may be answered with an un-
equivocal "Yes," qualified in certain specifics. In the field
of clinical investigation, which encompasses the under-
standing of the mechanisms of the differing disease entities
and clinical syndromes and the development and evaluation
of different treatment forms, the ability to make relatively
*Dr. J, Tinker, Chief of Department of Cardiac Anesthesia, Mayo
Clinic, Rochester, Minnesota, Correspondence quoted with permission.
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simple but accurate and quantifiable measurements of im-
portant variables has proved to be of the utmost value.
Equally, the value in specified circumstances of predictable
hazards, such as a complex surgical procedure or a surgical
procedure in a seriously ill patient (2), would be strongly
supported by a high proportion of cardiac and other specialty
surgeons. However, in the management of the acute syn-
dromes of ischemic heart disease, congestive heart failure
and other diseases of the heart, a variety of opinions exist
(3). Such issues characterize virtually all frontiers of car-
diovascular medicine today. The principles of invasive
hemodynamic measurement are reasonably established; the
applications-who, when, where, and so forth-remam to
be completely defined.
Principles
Cardiac catheterization. The measurement of cardiac
output and its determinants and the effect of drugs on blood
vessels were already known in the early part of this century
because of the work of the giants of cardiovascular physi-
ology-Frank (4), Starling (5), Dale (6) and their colleagues
and students. These fundamentals were not applied in car-
diology or medicine, or even considered remotely relevant,
until the late 1940s when Cournand (7), Bing (8), Dexter
(9) and their co-workers in this country and McMichael and
Sharpey-Schafer ( 10) in England applied the novel personal
experiment (or experience) of Forssman ( 11) to obtain mea-
surements of the oxygen saturation of central venous blood
and concomitantly measure pressure in the right side of the
circulation in human subjects. Right heart catheterization
and pulmonary artery blood sampling allowed the mea-
surement of cardiac output by application of Fick 's prin-
ciple; measurement of right and left atrial (pulmonary wedge)
pressures allowed estimation of the preload of each ventri-
cle; and a knowledge of pulmonary and systemic arterial
pressures permitted calculation of vascular resistances with
acceptable accuracy. The Fick method for cardiac output
determination was laborious, time consuming and of limited
repeatability. The catheterization techniques then available
depended on the manipulation of semi-stiff catheters (bor-
rowed in part from the urologic disciplines) using radiologic
imaging of low efficiency. Right heart catheterization inev-
itably resulted in atrial and ventricular ectopic rhythms and
was attended by a significant complication rate (12), even
in patients who were not critically ill.
Swan-Ganz balloon flotation catheter. Concerned by
the lack of understanding of the pathophysiologic processes
underlying acute myocardial infarction and other clinical
ischemic cardiac syndromes, we believed that the applica-
tion of catheterization techniques was essential to a mean-
ingful investigation of many aspects of these conditions.
This required a rethinking of the principles of cardiac cath-
eterization so as to make them compatible with the envi-
ronment in which they were to be applied (13). We won-
dered whether a highly flexible catheter could be made to
enter the pulmonary artery consistently and safely without
the use of fluoroscopy. Bailon-tipped catheters had been
used in many circulatory investigations (14,15) and pro-
cedures (16,17). Within a few months of the development
of the pressure-monitoring, flexible, flow-guided, balloon-
tipped, 1.5 mm (5F) catheter, 100 consecutive patients had
been studied in the cardiac care unit at Cedars of Lebanon
Hospital in Los Angeles. The findings were reported in the
New England Journal of Medicine in 1970 (18) and dem-
onstrated the following critical points: bedside catheteriza-
tion of the pulmonary artery was possible without the use
of fluoroscopy in a very high proportion of patients in whom
the procedure was attempted. More importantly, successful
catheterization could be achieved even in the sickest pa-
tients, and failures were usually associated with difficulty
in transvenous manipulation from the arm or with the pres-
ence of a large right atrium and tricuspid regurgitation.
Catheterization of the heart by this method could be achieved
by physicians not necessarily possessing the manipulative
skills acquired in a cardiac catheterization laboratory. Com-
plications, in particular significant arrhythmias, were un-
common. Most importantly, the application of these tech-
niques was feasible within the environment where they were
required. Furthermore, after appropriate educational pro-
grams, the then emerging discipline of critical care nursing
proved to be highly accepting of the application of physi-
ologic monitoring and demonstrated major growth and ex-
pertise in the discipline (19,20).
Role of measurements of ventricular filling pres-
sure. The most important initial consequence of these de-
velopments was the ability to measure right and left ven-
tricular filling pressures. A relation between these values
had been demonstrated in normal subjects (21), and the
assumption was made that this relation also pertained to
patients with a variety of diseases. In fact, nothing was
further from the truth. Ischemic heart disease-a common
overt or covert component of Western civilization and the
process of aging-characteristically affects one ventricle to
a greater extent than the other. Pulmonary disease affects
the right ventricle to a greater degree than the left. There-
fore, it is of little surprise that an understanding of the
fundamentals of circulatory dynamics in the diseased state
requires, at a very minimum, an adequate description of the
preload of both right and left ventricles (22). It is of some
interest that a short decade ago considerable debate and
discussion were addressed to the issue of whether central
venous pressure measurements allowed an assessment of
circulatory dynamics adequate for most clinical purposes.
Because a measurement is obtained readily does not mean
that it is necessarily useful. It was concluded that, under
many circumstances, measurement of central venous pres-
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sure was more likely to mislead than to provide effective
guidance in the treatment of cardiopulmonary diseases (23) .
Measurement of Cardiac Output
Although indocyanine green indicator-dilution curves were
used extensively in catheterization laboratories for the mea-
surement of cardiac output (24), the applicationof this tech-
nique at the bedside or in the operating room was beset by
majorpractical difficulties. The useof densitometricdevices
or even the spectrophotometric analysis of the dye concen-
tration of individual blood samples was required. These
techniques were time consuming, required a relatively skilled
laboratory staff and. hence, were unsuitable for practical
clinical application. Because cardiac output was difficult to
measure a decade ago, clinicians believed that a knowledge
of its magnitude and its directional changes could not con-
tribute to patient management!
Thermodilution measurement technique. The provi-
sion of a pulmonary artery thermistor and the addition of a
catheter for injectionof cold indicator (25,26) permitted the
practicalmeasurement of cardiacoutput in a widepopulation
of critically ill patients and in a variety of clinical environ-
ments. Incorporation of the thermistor in the catheter shaft
andan additionallumen for rightatrial injection(27) allowed
the application of simple computational devices for the im-
mediate calculation of cardiac output. Measurement of car-
diac output by thermodilution technique with injection of
cold indicator into the right atrium and definition of the
temperature change in the pulmonary artery is now simple
and feasible. It is a bedside procedure, usually performed
by nursingpersonnel, that is both precise and accuratewhen
performed correctly (27-29). Previously, the measurement
of cardiac output was unusual in a clinical setting, consid-
ered irrelevant by most physicians, and rarely, if ever, ob-
tained with the thermodilution method. Today, millions of
estimations of cardiac output are carried out annually in a
clinical setting; probably 95% of these are made by
thermodilution.
In the normothermic nonanemic patient suffering from a
variety of illnesses, the cardiac index usually exceeds 2.2
liters/min per rrr'. From the cardiovascularstandpoint. such
patients have a favorable prognosis. Moderate depression
of cardiac index (less than 2.2 but greater than 1.8 liters/
min per rrr') represents a borderline cardiac output that is
barelyadequate to meet ordinary metabolic needs. A cardiac
index substantially less than 1.7 liters/min per rrr' is usually
associated with a poor to extremely poor prognosis unless
a reversible cause such as hypovolemia is identified and
promptly treated (Fig. I).
Clinical significance of measurement of cardiac in-
dex. An isolated and accurate measurement of cardiac in-
dex is of major prognostic significance, and can alert the
physician to the need for appropriate therapeutic response.
This is in contrast to endocrinedisorders, neoplastic diseases
and infectionsthat may be regardedby physiciansas' 'slow"
processes. In many aspects of cardiovascular disease, out-
come is determined by " fast" phenomena, the fundamental
frequency of cardiovascular events being one cardiac cycle.
These events include arrhythmias, pulmonary edema. pul-
monary embolism. cardiac tamponade and ischemic necro-
sis. Initial clinical findings may fail to distinguish a patient
with impending circulatory collapse from one who may
experience a relatively benign outcome. For example. a
severe reduction of cardiacoutput does not necessarily result
in a corresponding decrease in arterial blood pressure. but
can be masked by vasoconstriction in the peripheral arterial
and venous beds. Also, severe pulmonary congestion may
precede symptoms of acute pulmonary edema by several
hours. However, effective intervention is frequently with-
held because of the inherent "optimism" (or fatalism) of
medical care personnel who fail to search for critical in-
formation in a timely manner. Although we are in no way
advocating unnecessary prolongation of a life not worth
living, we believe that effective action in situations that
permit satisfactory restoration of human capabilities is the
moral. ethical and social basis of medicine and a first line
responsibility of its practitioners. The penalty for errors of
serious omission may be great-it is paid for by the patient.
Control of Cardiac Output
The determinants of myocardial oxygen consumption are
also principal factors in the control of cardiac output (30).
In depression of myocardial contractility due to disease or
the effects of pharmacologic agents, the heart is critically
afterload-dependent. In contrast to the behavior of the nor-
mal heart or the heart in systemic hypertension, substantial
increases in cardiac output accompany a reduction in left
ventricular outflow impedance. Such interventions. readily
achieved in modern critical care units, can increase cardiac
output by as much as 50%. restore organ perfusion, reverse
metabolicacidosisand significantly improveshort-term and,
hence, the potential long-term prognosis. Effective appli-
cation of impedance reduction by systemic arterial vaso-
dilator drugs is dependent on a knowledge that the cardiac
output is, in fact, substantiallyreducedand that the reduction
is associated with a high systemic vascular resistance-a
major component of aortic impedance (31). Similarly, the
"sick" ventricle is preload-dependent in several clinical
circumstances. For this reason, we have recommended
maintenance of left ventricular filling pressure (wedge pres-
sure) at 15 to 18 mm Hg. The normal left ventricular filling
pressure is 6 to 12 mm Hg (32) and the normal right ven-
tricular filling pressure is 2 to 5 mm Hg. Modest deviations
from these levels may be associated with adverse cardiac
and pulmonary changes. The implications of manipulation
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Figure 1. Schematic representation of the relation of car-
diac index to prognosis in cri ticall y ill patients. The left
panel indicate s the probab ility of surviv al based on a
reasonably accurate determination of cardiac index and
the assumpti on that cardiac index does not substantively
improve in a reasonably short time . For patients whose
cardiac index is 2.0 or greater . the likelih ood of survival
is not likely to be related to depression of cardiac perfor-
mance; for those with a card iac index of 1.0. the proba-
bility of survival is small and mortality i, due to inadequate
tissue perfusion . In the right panel. the likely time to
death in hours is also related to cardiac inde x. A cardiac
index of 1.5 or less will result in a high mortality rate and
a relatively short dur ation of survival unle ss the card iac
index increa ses spontaneously or can be increased by ther -
apeutic intervent ions; this adverse prognosis does not nec-
essarily pertain in altered metabolic state, such as hy-
pothermia and post-anesthesia .
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of afterload and preload are represented diagrammatically
in Figure 2.
A decade ago, the cardiologist 's therapeutic mainstay
consi sted of digitalis, diuretic drugs and vasopressors . Ma-
nipulation of preload and afterload was not regarded as
feasible or relevant in " heart failure ," although some car-
diac surgeons favored maintenance of high left atrial filling
pressures in the postoperative patient. Recognition and man-
agement of hypovolemia, frequentl y caused by overenthu-
siastic use of diuretic drugs. characterized the mid 1970s;
by the end of the decade , a variety of short- and long-acting
vasodilator drugs were applied with benefit in patient s with
acute or chronic heart failure. In each of these instances,
application relied heavily on hemodynamic measurement.
Hemodynamic Measurements
and Monitoring in Clinical Practice Today
The specifics of medical practice are determined by atti-
tudes. resources , skills and the perception of the possibility
to alter the outcome of disease process favorabl y and sub-
stantively. Thus, hemodynamic monitoring is indicated when
there is a significant likelihood that the information derived
from the monitoring procedures will affect decisions con-
cerning prognosis and therapy (33). The potential adver se
events ("complications") associated with such procedures
must approach an irreducible minimum. From these state-
ments of principle, it follow s that if no significant inter-
vention is contemplated or possible , then hemodynamic
measurement cannot benefit the patient and should not be
performed. Likewise, if the appropriate levels of under-
standing of pathophysiology and cardiovascular therapy and
the technical skills of medical and paramedical personnel
responsible for procedures are lacking, deficient or unavail-
able , hemod ynamic measurements should not be carried out.
Potential complicationsand limitations. Complications
associated with the use of balloon flotation catheters have
been well described (34 ,35). The most serious of these is
rupture of the pulmonary artery (36,37) associated either
with migration of a catheter tip into a distal vessel. or with
injudicious inflation of a balloon in a fragile pulmonary
artery branch of a diameter not substantially greater than
that of the catheter shaft.
In addition to the complications related to insertion. ad-
vancement and mainten ance, important human " compli-
cations" of application still exist. The acquisition of skill
to insert and position a flotation catheter safely is only the
first, and certainly not the last. responsibility of the phy-
sician who employs hemodynamic measurements in clinical
practice . Regrettably, the inherent simplicity and safety of
the insertion technique have fostered a cavalier attitude among
many physicians and paraprofe ssional personnel. so that
established procedures are allowed to deteriorate . Many
physicians (including cardiologists) do not sufficiently com-
prehend the physical principle s underlying the measurement
of pressure (38) or blood flow (39). Because of preoccu-
pation with the technical aspects of catheter insertion and
failure to provide adequate supervision for physicians in
training. sloppy habits and inferior techniques have been
allowed to proliferate. Owin g to inexperience or ignorance .
many physicians fail to recognize artifacts in pressure sig-
nals that commonly occur during record ings of pressures
utilizing fluid-filled catheters. Of even greater significance
is the failure of many treating physicians to understand the
meaning of physiologic data, its relat ion to the clinical state
and the associated issues of progno sis and optimal therapy.
In our opinion. this represent s a retrogressive step from the
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situation a decade ago, when hemodynamic measurement
was the interest and the responsibility of investigative phy-
sicians. Widespread and relatively intensive training in the
relevant aspects of cardiopulmonary physiology and car-
diovascular pharmacology characterize the subspecialties of
anesthesia and critical care. We believe that it is essential
that physicians responsible for hemodynamic measurements
be trained in these fundamentals, have appropriate knowl-
edge of the principles of measurement of blood flow and
intravascular pressures, be skilled in the insertion of cath-
eters and be capable of committing both time and effort to
the management of critically ill patients.
Indications. The indications for hemodynamic moni-
toring in clinical practice are extremely diverse and are
increasing, but the fundamental requirements stated earlier
remain. The broad indication for invasive measurements can
properly be restated, that is, when the availability of hemo-
dynamic descriptors can complement the etiologic and func-
tional diagnosis, define the likely temporal progression of
the changing pathophysiology and modify, or possibly mod-
ify, the therapeutic approach to management.
Applications
The following commentary relates to application by disci-
pline. in contrast to disease, and presupposes the existence
of conditions that permit successful application of the
procedures.
Diagnostic cardiac catheterization. The flexible f1ow-
guided balloon-tipped cardiac catheter has greatly reduced
the time, skill levels and complications involved in an ef-
fective right heart catheterization (40). As a general ap-
proximation, manipulative and fluoroscopic times may be
reduced by half for right heart catheterization in patients
studied under fluoroscopy in the cardiac laboratory. It is
unusual for catheterization of the pulmonary artery with the
balloon flotation catheter to require more than 30 seconds.
Figure 2. The relation of preload and afterload to cardiac index in normal
subjects and patients with heart failure. The term heart failure as used here
relates to depressed cardiac function and not to the clinical manifestations
of congestion and low forward flow. In the left panel. the relation to
preload as defined by left ventricular filling pressure (L.V.F.P) is shown.
Cardiac index in the patient with heart failure is highly preload-dependent;
at even "normal" levels of left ventricular filling pressure, the cardiac
output may be inadequate to satisfy metabolic demands. In the normal
heart, not only is the cardiac performance substantially greater at all levels
of filling pressure, but also even at low filling pressures the resulting
magnitude of cardiac index exceeds that necessary for metabolic survival.
In the right panel, the relation of systemic vascular resistance (S.V.R.)
to cardiac index is shown. Not only is the normal heart less directly
embarrassed by the magnitude of systemic vascular resistance (as an im-
portant component of aortic impedance), but also the absolute level of
cardiac index in the patient with heart failure is depressed to levels of
metabolic inadequacy. Reduction of systemic vascular resistance in both
normal subjects and patients with heart failure resulted in an increase in
cardiac index, but only in the patient with heart failure is the absolute
value moved from a critically reduced to an adequate range.
Indeed, a colleague once remarked that he did not see how
physicians could be trained in manipulative catheterization
skills if the balloon flotation catheter was routinely used in
catheterization laboratories-a somewhat irrational objec-
tion to its application.
In complex congenital malformations of the heart, it is
frequently difficult, if not impossible, to manipulate semi-
stiff cardiac catheters into a ventricular chamber or great
artery. The application of a flexible balloon flotation catheter
under these circumstances almost always permits entry to a
ventricle and great vessel, whose definition is then greatly
facilitated (41).The ability to establish an anatomic diag-
nosis with minimal delay or intracardiac trauma is of great
importance in the management of newborns and infants with
congenital heart disease. Application of the balloon flotation
catheter, together with consequent angiography, has enor-
mously facilitated effective and safe diagnostic procedures
in such patients.
Anesthesia in cardiac surgery. Maintenance of the car-
diopulmonary integrity of patients during surgical interven-
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tion is essential. Although the benefits of management under
conditions of hemodynam ic monit oring have been appre-
ciated and extensively applied by the discipline of anesthe-
siology, some senior surgeons have doubted and continue
to doubt that the benefit of improved management outweighs
the inherent risks and, perhaps more importantly, the logistic
incon veni ences associated with measurement and monitor-
ing procedures. Difficulties increase when the contemplated
procedure is major, complex and of long duration. In ad-
dition, morbidity and mortality are importantly related to
the pat ient' s condition before operation . Hence , the indi-
cations for hemodynamic mea surements and monitoring in
operative patients are related both to the contemplated sur-
gical procedure and to the underlying cardiovascular health
of the subject (2,42).
In anesthesia, the most rapid acceptance and application
of hemodynamic measurement have been in the field of car-
diovascular surgery (43) . In the transition from surgical
procedures on essentially healthy myocardium (congenital
malformations) to operations on patients with inherently
diseased myocardium (ischemic heart disease), the contem-
porary cardiovascular surgeon has accepted a patient group
whose inherent survival characteristics are less than favor-
able. Such patients have many of the criteria that define
surgica l " high risk ," including relat ively advanced age,
prior myocardial infarction , angina pectori s , hypertension ,
aortic aneurysm, carotid artery disease and stroke in the
presence of a variet y of other general conditions , such as
diabetes, peripheral atherosclerosis, renal disease and im-
muno suppressive state s. To this galaxy of surgical deter-
rent s . pat ient s with valvular heart disease who previously
presented clinical manifestations early in life are now seen
in the fifth , sixth and seventh decades.
This, therefore, is the current matrix of patients pre-
senting f or potential relief by means of cardiac surgery.
The intrinsic risk of mortality and morbidity is great. This
risk may be enhanced by the occurrence of significant myo-
card ial ischemia during premedication , induction. intuba-
tion and general support until cardi opulmonary bypass is
success fully initiated . In such patients. hemodynamic mon-
itoring is used to reco gnize reflex vasomotor changes , hy-
poxia and adverse effects on ventricular myocardium (44) .
To be more specific, the preoperative states that parti c-
ularly fa vor appli cation ofhemodynamic monitorin g include
prior evidence of myocardial infarcti on. reoperation in pa-
tient s previou sly subjected to coronary artery bypass graft-
ing (45). left main (46 ) or complex coronary artery disease.
valvul ar heart disease associ ated with significant coronary
atherosclerosis. mitral stenosis in the elderl y , mitral stenos is
with severe pulmonary hypertension and multi valvular dis-
ease. To the contemplative physician responsible for the
care of patients undergoing cardi ac surgery. the uncompli-
cated course that is usually followed is almost miraculous.
Nevertheless. it is logical to believe that patients with even
more severe limitations-and, therefore. with more to gain-
will continue to present as surgica l ca ndidates . Preservation
of the currently satisfactory outcome of surgery for the va-
riety of cardiac disorders is no longer dependent only on
the exce llence of surgical technique. but also on the details
of intra- and postoperative management by the anesthe-
siologist and his physician colleagues (47). A recent study
(48) demon strated that more than 60% of adverse event s
were not recognized by ex perienced ca rdiovascular anes-
thesiologists " blinded" from concurrent hemodynamic
measurements.
Application in general surgery. The increased mort al-
ity and morbidity of patients more than 65 years of age
undergoing general surgi cal procedures (two to five time s
greater than mortality and morbidity in younger patients)
presents a contemporary challenge of both moral and sci-
enti fic import . This unsatisfactory situation pertains because
elderly patients have . by the ir very nature. a signifi cant
prevalence of intrinsic coron ary artery disease and an in-
cidence of previous cardiovasc ular disease. Hence . opera-
tion in such patient s. without careful regard for the con-
sequences of myocard ial ischemia, will result in an
unsatisfactory outcome in a relatively large proportion of
patient s (49) .
An increasing number of vascular procedures (50) . and
in particular resection of intrathoracic aneurysms . are now
conducted under conditions of hem odynamic monitorin g
(5 1,52) . Similar considerations apply to prostatectomy, an
operation common in the elderly coronary prone male . In
patient s undergoing this procedure . the prevalence rate of
intrinsic coronary disease is high . and the stres ses on the
circulation by alteration in intravascular volumes (and os-
molarity) during the operation may be great (53). For the se
reasons the anesthesiologist responsible for the ongoing care
of the elderly patient with a significant surgical . 'problem"
must test for the presence of coro nary artery disease and
measure and monitor such patient s before and during the
course of their operation (54). Although the majority of
elderly patients may not prove to have important cardiac or
vascular disorders. a proport ion must be treated with great
skill durin g and after their operation to avoid significant
ischemic epi sode s and the potent ial of a disastrou s cardiac
event. Thi s is particularly true in patients who require op-
erations of long duration . such as complete hip replacement
or extensive resection for cancer (55). In such patients it is
mandat ory that ischemic event s due to the presence of sub-
critical coronary atherosclerosis be avoided or at least
min imized.
A recent report (56) concerned the application of hemo-
dynamic monitoring in patients with prior myocard ial in-
farction undergoing noncard iac surgery . Compared with
nonmonitored patients. the monit ored patients demonstrated
a reduction in perioperative infarct ion rate from 7.7 to 2.3%
overall and from 28 to 5% in those in whom infarction was
HEMODYNAMIC MEASUREMENTS IN CLINICAL PRACTICE J AM cou, CARDlOl
1983;I:103-13
109
more recent than 6 months. The mortality associated with
perioperative infarction was high. Although the series re-
ported was not concurrent, their characteristics and opera-
tions were closely similar, and the reponed differences in
outcome are striking.
Cardiac intensive and coronary care units. Hemody-
namic measurement as defined in this review has been in
the forefront of the development and application of knowl-
edge in cardiac care, particularly in ischemic states (57-
61). However, a significant concern about the appropriate-
ness of application of hemodynamic measurement in the
individual patient still exists. In our opinion, this is due to
a misconception on the part of cardiologists regarding isch-
emic cardiac syndromes. Conventional authorities suggest
that hemodynamic monitoring is relevant only in the com-
plicated patient with severe heart failure or established car-
diogenic shock.
This wisdom ignores the fa ct that myocardial damage in
acute myocardial infarction is a temporarily rapid process
(62) and outcome is determined largely during the first hours
after the onset of symptoms. Hemodynamic measurements
(including noninvasive testing for abnormalities of regional
wall motion and global function) will identify those patients
in whom the territory at risk is large and in whom inter-
ventions, such as thrombolysis (63 ) or prompt myocardial
revascularization (64) , may significantly limit necrosis or
be lifesaving. The applications of hemodynamic measure-
ments in patients relatively late in the course of complica-
tions of acute myocardial infarction, although generally ac-
cepted, are restricted to fine tuning of a fundamental medical
disaster.
As a general recommendation, we believe that early
hemodynamic measurements are appropriate in patients with
the greatest vulnerability. These include the young and those
with a first infarct, no prior ischemic events and early evi-
dence of circulatory collapse or serious arrhythmias. For
ongoing therapy, management based on hemodynamic prin-
ciples should be employed (65) . Demonstration of elevated
left ventricular filling pressures and low cardiac output with
an elevated peripheral vascular resistance indicates a poor
prognosis; the time scale for a definitive decision is minutes
to hours, not days or weeks.
The presence ofsignificant cardiac arrhythmias suggests
a specific application of the balloon flotation catheter . Min-
iature extrusion and wiring technology has now permitted
the development of multipurpose balloon flotation catheters
(66 ,67) that bear electrodes for sensing right ventricular and
right atrial electrical activity; they also provide a site for
stimulation of either the atrium or the ventricle. Differential
stiffening of the more proximal portion of the balloon flo-
tation catheter allows for appropriate contact of the elec-
trodes with the inflow tract to the right ventricle and the
junction of right atrium and superior vena cava. The use of
these catheters permits the accurate identification of a wide
variety of cardiac arrhythmias that cannot be diagnosed with
confidence from surface electrocardiographic tracings alone.
Certainty of diagnosis is essential to the appropriateness of
the treatment selected. The application of the multielectrode
catheter systems allows for the evaluation or temporary (usu-
ally emergent) application of atrial, atrioventricular or ven-
tricularpacing. Quantitative measures of cardiac performance
are possible from the same catheter device. Such an acute
evaluation may define the optimal " long-term" pacemaker
strategy for a given patient with arrhythmic or conduction
disease.
Patients with chronic heart failure present a great man-
agement challenge to the physician. not only in terms of
prolongation of existence, but also in the quality of life
while existence continues. Measured hemodynamic im-
provement (increase in cardiac index, decrease in cardiac
filling pressures) caused by judicious application of vaso-
dilator drugs (68,69) may be complemented by an appro-
priate program of physical conditioning to improve the con-
tentment and physical and emotional capacity of patients
with chronic heart failure. Notwithstanding adverse inter-
mediate and long-term prognosis in these patients, the im-
provement in activity levels and life acceptance under such
circumstances has been remarkable in certain instances.
In summary, hemodynamic measurements Can be applied
in a variety of patients with primary cardiac disease to eval-
uate acute cardiac dysfunction and to identify deficiencies
in cardiac performance and the associated physiolo~ic fac-
tors. They allow a rational application of pharmacologic and
other interventions, as well as a prompt judgment concern-
ing the efficacy of such interventions. In patients with chronic
cardiac dysfunction, an effective and accurate evaluation of
the functional status and the acute response to therapy can
be determined; ultimately this affects the patient's long-term
outcome.
Medical intensive care units. Appreciating the logistic
reality that patients with cardiovascular disease (just con-
sidered) are frequently admitted to medical intensive care
units, certain important subgroups of patients without car-
diac disease also require hemodynamic monitoring (70 ) .
Principally, these include patients with preshock syndromes
or features of noncardiogenic shock. Although cardiogenic
shock is frequently related to irreversible destruction of
myocardium and associated with a poor prognosis, the po-
tential salvage of patients suffering from noncardiogenic
shock remains substantial. Of particular significance are
patients with sepsis. combined pulmonary and cardiovas-
cular disease and mild to moderate disease insults associated
with serious immunosuppressive disorders. In such circum-
stances, it is helpful to identify the contribution of changes
in systemic vascular resistance, filling pressures for the left
and right ventricles and alterations in pulmonary resistances
as well as acid-base balance and gas transfer in order to
evaluate such patients effectively. Only then can an appro-
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priate therapeutic plan be devised in complex multisystem
disease. The role of intrinsic depression of myocardial func-
tion in morbid situations of primary noncardiac origin has
seldom been conceptually considered and has rarely been
subjected to analytical investigation.
Pulmonary intensive care. Investigation continues in
the cardiac component of the pathophysiology of primary
pulmonary disorders. Measurement of pulmonary artery di-
astolic and capillary wedge pressures allows differentiation
between left heart failure, pulmonary embolus or chronic
pulmonary disease with relative ease and a high degree of
certainty. The presence or absence of right ventricular hy-
pertrophy is a principal determinant of the response of the
right ventricle to significant increases in afterload. Failure
of the right ventricle may prove to be the real ,. Achilles'
heel" in patients with acute or chronic pulmonary disorders.
The accuracy ofmeasurements ofpulmonary. ventricular
or atrial pressure in patients supported by mechanical ven-
tilators has also been questioned. The measurements them-
selves remain simple and intrinsically correct; the interpre-
tation becomes more difficult. The circulatory transmural
pressure is the difference between intravascular and extra-
vascular pressure. Appropriate correction for ventilator-gen-
erated pressures allows interpretation of the physiologic state.
Also with use of the thermodilution technique, cardiac out-
put and index may be effectively measured with reasonable
accuracy consistent with the physiologic environment. Car-
diac output decreases during the positive phase of assisted
mechanical ventilation and increases during passive expi-
ration. Therefore, the true variability in intravascular pres-
sures and in measured cardiac output must be considered
with relation to the phases of supported ventilation.
Trauma. Management of the injured patient presents a
series of widely different logistic situations. Such patients
constitute an important cohort of persons with gross dis-
turbances in the function of the heart and lungs. In 1977,
vehicular injuries alone resulted in 50,000 deaths with 1.9
million subjects suffering from disabling injury (71). Trauma
remains the leading cause of death in subjects under 40
years of age who otherwise would have the best prognosis
in terms of survival expectancy and life satisfaction. Al-
though morbidity and mortality related to trauma and bums
are primarily related to severity of injury and to delays in
the initiation of definitive care, important changes in pul-
monary vascular resistance from a variety of causes also
develop in such patients. These causes range from fat or air
embolus to right ventricular contusion, hemopericardium
and neurogenic pulmonary edema. Although hemodynamic
measurement is clearly inappropriate during field stabili-
zation or transportation to a primary medical facility. it
remains (or will become) appropriate to the functions of
regional trauma-burn-sepsis centers (72). Hemodynamic data
not only are relevant to operative risk, but also permit op-
timal preoperative preparation and maintenance of intra-
operative fluid and electrolyte balance. A significant pro-
portion of the victims of traumatic or burn injury are also
elderly. Hence. after stabilization, the victim of trauma or
severe burns who is at risk for survival may benefit from
hemodynamic measurement and monitoring in the recog-
nition of occult ischemic heart disease.
Patients presenting with acute' 'surgical emergencies."
trauma. burns or sepsis may develop acute respiratory dis-
tress syndrome and right ventricular failure (73,74!. The
secondary (late) mortality rate in such patients is related to
these phenomena. The use of interventions conceptually
designed to rectify abnormalities of pulmonary and right
ventricular function may help reduce the excessive late mor-
tality and morbidity associated with chest and general trauma.
With the exception of trauma centers, routine hemodynamic
measurement in the care of such patients is in its infancy.
However, pressure measurements alone will define the pres-
ence and magnitude of hypovolemia. Fluid transfers in burn
victims are of such magnitude and rapidity that hemody-
namic measurements appear to be a rational adjunct to care-
fully programmed and effective treatment. Similar concerns
relate (uncommonly) to the critically ill pregnant patient
(75).
Impact of Hemodynamic Measurement
The fundamental role of the heart is to deliver blood to the
organs and tissues of the body in sufficient quantity to meet
the changing requirements of tissue metabolism. Blood is
returned from the tissues of the body for effective disposal
of the products of metabolic activity through the liver, lungs
and kidneys. Modern hemodynamic measurement permits
estimation of the magnitude of cardiac output with a high
degree of precision and with acceptable accuracy in the
majority of clinical circumstances, so that the significance
of apparently small changes in the magnitude of cardiac
output can be interpreted. Currently available hemodynamic
measurements also provide direct information concerning
the determinants of cardiac output and the distributive be-
havior of the pulmonary and systemic vascular systems.
Over the past decade, the availability of such measurements
in virtually all subdisciplines of medicine has importantly
and positively affected both understanding and clinical
practice.
Pathophysiology of disease states. Primary disease of
the heart and lungs is a frequent and important component
of illness in human beings. Cardiac and pulmonary func-
tional changes also characterize many noncardiac condi-
tions. Hemodynamic measurements have provided im-
proved understanding of the dynamics of cardiogenic and
noncardiogenic shock, the various anginal syndromes, and
the changing dynamics of evolving myocardial infarction
and cardiac arrhythmias. In the context of acute cardiac
disease, such measurements have importantly demonstrated
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the lag time between clinical findings and symptoms. in
relation to hemodynamic derangement and to the dynamic
nature of such changes. Thus, hemodynamic measurements
serve as a reference point for the relation of symptoms.
clinical findings and the responses of other noninvasive mea-
sures of cardiovascular function. It is on the basis of such
measurements that the natural history of primary and sec-
ondary cardiac and pulmonary disorders may be adequately
described as a basis for successful intervention.
Clinical research. Hemodynamic measurement repre-
sents a principal tool of clinical research on pharmaceutical.
electrical and mechanical interventions . It has permitted the
evaluation of vasoconstrictor. vasodilator and contractility
modifiers , as well as the effect of agents believed to have
solely nonvascular actions (for example. antiarrhythmic
agent s). These techniques further allow for an accurate eval-
uation of the direction. magnitude and rate of change of
cardiac output and its determinants as a consequence of
therapeutic interventions . These methods have been used in
the evaluation of virtually all new cardiovascular drugs in-
troduced over the past decade .
Patient care. In situations where risk can be predicted
with reasonable certainty. hemodynamic measurement and
monitoring continue to gain increasing acceptance. Debate
still exists concerning which patients (or conditions) not
being treated surgically would benefit from invasive mea-
surements . This debate is natural. If the probability of an
adver se risk cannot be predicted with a reasonable degree
of certainty. then procedures that may be associated with
intrinsic stress and hazard for an unknown benefit are justl y
questioned. In contrast , operative procedures are defined in
advance and the preoperative health of the patient also is
known . Therefore, a risk-benefit ratio of the use of hemo-
dynamic measurement can be determined more readily in
the surgical than in the medical patient.
Surgical patient. Growing acceptance of hemodynamic
monitoring as a routine but selective part of patient care is
evident in the discipline of anesthesiology and certain other
surgical subspecialties. The high risk patient group undergo-
ing cardiovascular surgery includes patients of more ad-
vanced age. patients with complex coronary artery disea se
(including left main obstruction). associated valve disease
or an ejection fraction of less than 0.35 and candidates for
cardiac reoperation. Patients undergoing multivalve surgery
or elderly patients undergoing single valve surgery are also
benefited. Hemodynamic measurement may be of less ben-
efit in younger patients-those with unimpaired resting ven-
tricular function. no primary myocardial infarction and a
good hemodynamic profile . Patients unde rgoing treatment
of thoracic aneurysm or aortic dissection can experience
profound alteration in left ventricular afterload and in blood
volume . Fewer patients with vascular procedures on the
abdominal aorta and iliofemoral system will necessarily benefit
from hemodynamic monitoring . High risk may be associated
with prostatectomy, becau se a substantial number of patients
undergoing this procedure have overt or covert coronary
artery disease . Major surgery . particularly in the elderly,
involving large shifts in blood volume (for example. in
exten sive resection of malignancies) necessitates careful
con sideration of the possible benefit s of hemodynamic mon-
itoring . Trauma. sepsis and burn surgery are increasing the
application of hemodynamic monitoring techniques. Certain
SUbdisciplines. including obstetrics and gynecology. eye ,
ear , nose , throat and plastic surgery. only occasionally re-
quire hemodynamic measurements .
Nonsurgical patient. Medically designated diseases have
less well defined indications and contraindications for in-
vasive hemodynamic measurements . Another decade will
elapse before the role of hemodynamic measurements is
clearly established. One important issue is to determine the
limits of sensitivity and errors of secondary noninvasive
measurements of cardiovascular performance . If and when
these can be defined . then substitution for invasive mea-
surement techniques can be undertaken . However. as with
the earlier attempts at appl ication of hemodynamic mea-
surement using the semi- stiff catheter systems in the clinical
environment. technologic characteristics will preclude many
of these methods becau se of environment . cost and non-
continuity of application .
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